nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—RET—enteric nervous system—narcolepsy	0.248	0.275	CbGeAlD
Regorafenib—RET—autonomic nervous system—narcolepsy	0.0871	0.0964	CbGeAlD
Regorafenib—NTRK1—midbrain—narcolepsy	0.0335	0.0371	CbGeAlD
Regorafenib—FGFR2—brainstem—narcolepsy	0.02	0.0221	CbGeAlD
Regorafenib—FGFR2—forebrain—narcolepsy	0.0193	0.0213	CbGeAlD
Regorafenib—RAF1—brainstem—narcolepsy	0.0184	0.0204	CbGeAlD
Regorafenib—RAF1—forebrain—narcolepsy	0.0178	0.0197	CbGeAlD
Regorafenib—BRAF—midbrain—narcolepsy	0.0176	0.0195	CbGeAlD
Regorafenib—PDGFRA—forebrain—narcolepsy	0.0167	0.0185	CbGeAlD
Regorafenib—FGFR1—medulla oblongata—narcolepsy	0.0164	0.0181	CbGeAlD
Regorafenib—DDR2—brain—narcolepsy	0.0157	0.0173	CbGeAlD
Regorafenib—KDR—forebrain—narcolepsy	0.0151	0.0167	CbGeAlD
Regorafenib—FGFR1—midbrain—narcolepsy	0.015	0.0166	CbGeAlD
Regorafenib—MAPK11—brain—narcolepsy	0.0148	0.0164	CbGeAlD
Regorafenib—RET—medulla oblongata—narcolepsy	0.0147	0.0162	CbGeAlD
Regorafenib—KIT—brainstem—narcolepsy	0.0139	0.0153	CbGeAlD
Regorafenib—RET—midbrain—narcolepsy	0.0134	0.0148	CbGeAlD
Regorafenib—TEK—medulla oblongata—narcolepsy	0.0134	0.0148	CbGeAlD
Regorafenib—FLT1—medulla oblongata—narcolepsy	0.0129	0.0143	CbGeAlD
Regorafenib—RAF1—medulla oblongata—narcolepsy	0.0128	0.0142	CbGeAlD
Regorafenib—TEK—midbrain—narcolepsy	0.0122	0.0135	CbGeAlD
Regorafenib—ABL1—brainstem—narcolepsy	0.0121	0.0134	CbGeAlD
Regorafenib—FLT1—midbrain—narcolepsy	0.0118	0.0131	CbGeAlD
Regorafenib—RAF1—midbrain—narcolepsy	0.0117	0.013	CbGeAlD
Regorafenib—BRAF—brain—narcolepsy	0.0111	0.0122	CbGeAlD
Regorafenib—KDR—medulla oblongata—narcolepsy	0.0109	0.0121	CbGeAlD
Regorafenib—EPHX2—brain—narcolepsy	0.0106	0.0117	CbGeAlD
Regorafenib—KDR—midbrain—narcolepsy	0.00997	0.011	CbGeAlD
Regorafenib—KIT—medulla oblongata—narcolepsy	0.00967	0.0107	CbGeAlD
Regorafenib—FLT4—brain—narcolepsy	0.00954	0.0106	CbGeAlD
Regorafenib—PDGFRB—medulla oblongata—narcolepsy	0.00945	0.0105	CbGeAlD
Regorafenib—FGFR1—brain—narcolepsy	0.00941	0.0104	CbGeAlD
Regorafenib—KIT—midbrain—narcolepsy	0.00884	0.00978	CbGeAlD
Regorafenib—PDGFRB—midbrain—narcolepsy	0.00863	0.00955	CbGeAlD
Regorafenib—ABL1—medulla oblongata—narcolepsy	0.00842	0.00932	CbGeAlD
Regorafenib—RET—brain—narcolepsy	0.00842	0.00932	CbGeAlD
Regorafenib—FGFR2—brain—narcolepsy	0.008	0.00885	CbGeAlD
Regorafenib—EPHA2—brain—narcolepsy	0.00786	0.0087	CbGeAlD
Regorafenib—ABL1—midbrain—narcolepsy	0.00769	0.00852	CbGeAlD
Regorafenib—TEK—brain—narcolepsy	0.00767	0.00849	CbGeAlD
Regorafenib—FLT1—brain—narcolepsy	0.00741	0.00821	CbGeAlD
Regorafenib—RAF1—brain—narcolepsy	0.00737	0.00816	CbGeAlD
Regorafenib—PDGFRA—brain—narcolepsy	0.00695	0.00769	CbGeAlD
Regorafenib—KDR—brain—narcolepsy	0.00627	0.00694	CbGeAlD
Regorafenib—KIT—brain—narcolepsy	0.00555	0.00615	CbGeAlD
Regorafenib—PDGFRB—brain—narcolepsy	0.00542	0.006	CbGeAlD
Regorafenib—ABCG2—medulla oblongata—narcolepsy	0.00531	0.00588	CbGeAlD
Regorafenib—ABCG2—midbrain—narcolepsy	0.00485	0.00537	CbGeAlD
Regorafenib—ABL1—brain—narcolepsy	0.00484	0.00535	CbGeAlD
Regorafenib—ABCB1—forebrain—narcolepsy	0.00362	0.00401	CbGeAlD
Regorafenib—CYP2C8—brain—narcolepsy	0.00314	0.00347	CbGeAlD
Regorafenib—ABCG2—brain—narcolepsy	0.00305	0.00337	CbGeAlD
Regorafenib—CYP2B6—brain—narcolepsy	0.00281	0.00311	CbGeAlD
Regorafenib—ABCB1—medulla oblongata—narcolepsy	0.00262	0.0029	CbGeAlD
Regorafenib—ABCB1—midbrain—narcolepsy	0.00239	0.00265	CbGeAlD
Regorafenib—ABCB1—brain—narcolepsy	0.0015	0.00166	CbGeAlD
Regorafenib—FLT4—Signaling Pathways—P2RY11—narcolepsy	0.000598	0.0062	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—CPT1B—narcolepsy	0.000581	0.00602	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000568	0.00589	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—SOCS2—narcolepsy	0.000521	0.0054	CbGpPWpGaD
Regorafenib—MAPK11—Gene Expression—CTNNBL1—narcolepsy	0.000518	0.00537	CbGpPWpGaD
Regorafenib—RET—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000509	0.00528	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—HCRT—narcolepsy	0.000508	0.00527	CbGpPWpGaD
Regorafenib—FGFR2—Cardiac Hypertrophic Response—TNF—narcolepsy	0.000494	0.00512	CbGpPWpGaD
Regorafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.000479	0.00497	CbGpPWpGaD
Regorafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.000479	0.00497	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—SOCS2—narcolepsy	0.000478	0.00496	CbGpPWpGaD
Regorafenib—KIT—Immune System—SOCS2—narcolepsy	0.000469	0.00487	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—HCRTR2—narcolepsy	0.000462	0.00479	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—HCRTR1—narcolepsy	0.000462	0.00479	CbGpPWpGaD
Regorafenib—BRAF—Downstream signaling in naïve CD8+ T cells—TNF—narcolepsy	0.000461	0.00478	CbGpPWpGaD
Regorafenib—RAF1—TWEAK Signaling Pathway—TNF—narcolepsy	0.000457	0.00474	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—PENK—narcolepsy	0.000453	0.0047	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—P2RY11—narcolepsy	0.000446	0.00462	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—SOCS2—narcolepsy	0.000446	0.00462	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—SOCS2—narcolepsy	0.000444	0.00461	CbGpPWpGaD
Regorafenib—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.000437	0.00453	CbGpPWpGaD
Regorafenib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.000437	0.00453	CbGpPWpGaD
Regorafenib—RAF1—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.000425	0.00441	CbGpPWpGaD
Regorafenib—ABL1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—narcolepsy	0.000415	0.00431	CbGpPWpGaD
Regorafenib—RAF1—Ceramide signaling pathway—TNF—narcolepsy	0.000411	0.00426	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—SOCS2—narcolepsy	0.0004	0.00415	CbGpPWpGaD
Regorafenib—ABL1—Immune System—SOCS2—narcolepsy	0.00039	0.00405	CbGpPWpGaD
Regorafenib—ABCB1—Allograft Rejection—HLA-DQA1—narcolepsy	0.000387	0.00401	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000386	0.004	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—TRH—narcolepsy	0.000385	0.00399	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—HCRT—narcolepsy	0.000379	0.00393	CbGpPWpGaD
Regorafenib—RAF1—Cardiac Hypertrophic Response—TNF—narcolepsy	0.000369	0.00382	CbGpPWpGaD
Regorafenib—ABCB1—Allograft Rejection—HLA-DQB1—narcolepsy	0.000362	0.00375	CbGpPWpGaD
Regorafenib—RAF1—Immune System—SOCS2—narcolepsy	0.000357	0.0037	CbGpPWpGaD
Regorafenib—FGFR2—MicroRNAs in cardiomyocyte hypertrophy—TNF—narcolepsy	0.000352	0.00365	CbGpPWpGaD
Regorafenib—PDGFRA—Allograft Rejection—TNF—narcolepsy	0.000344	0.00356	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—PENK—narcolepsy	0.000338	0.0035	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—HRH3—narcolepsy	0.000338	0.0035	CbGpPWpGaD
Regorafenib—MAPK11—Toll-like Receptor Signaling Pathway—TNF—narcolepsy	0.000328	0.0034	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—HCRTR2—narcolepsy	0.000325	0.00337	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—HCRTR1—narcolepsy	0.000325	0.00337	CbGpPWpGaD
Regorafenib—RAF1—Downstream signaling in naïve CD8+ T cells—TNF—narcolepsy	0.000319	0.0033	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—P2RY11—narcolepsy	0.000314	0.00326	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—HCRTR1—narcolepsy	0.000307	0.00318	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—HCRTR2—narcolepsy	0.000307	0.00318	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—HCRTR2—narcolepsy	0.000306	0.00318	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—HCRTR1—narcolepsy	0.000306	0.00318	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000299	0.0031	CbGpPWpGaD
Regorafenib—RAF1—Cytokine Signaling in Immune system—HLA-DQA1—narcolepsy	0.000298	0.00309	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—P2RY11—narcolepsy	0.000297	0.00308	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—P2RY11—narcolepsy	0.000296	0.00307	CbGpPWpGaD
Regorafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.000288	0.00299	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—TRH—narcolepsy	0.000287	0.00298	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—TAC1—narcolepsy	0.00028	0.0029	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—NPS—narcolepsy	0.00028	0.0029	CbGpPWpGaD
Regorafenib—RAF1—Cytokine Signaling in Immune system—HLA-DQB1—narcolepsy	0.000279	0.00289	CbGpPWpGaD
Regorafenib—ABCB1—Allograft Rejection—HLA-DRB1—narcolepsy	0.000275	0.00285	CbGpPWpGaD
Regorafenib—NTRK1—MAPK Signaling Pathway—TNF—narcolepsy	0.000271	0.00281	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—HCRT—narcolepsy	0.000267	0.00277	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000267	0.00277	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—HCRTR1—narcolepsy	0.000264	0.00274	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—HCRTR2—narcolepsy	0.000264	0.00274	CbGpPWpGaD
Regorafenib—RAF1—MicroRNAs in cardiomyocyte hypertrophy—TNF—narcolepsy	0.000263	0.00272	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—HCRTR2—narcolepsy	0.000262	0.00271	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—HCRTR1—narcolepsy	0.000262	0.00271	CbGpPWpGaD
Regorafenib—MAPK11—Regulation of toll-like receptor signaling pathway—TNF—narcolepsy	0.000256	0.00266	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—P2RY11—narcolepsy	0.000255	0.00265	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—CHKB—narcolepsy	0.000253	0.00262	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—CHKB—narcolepsy	0.000253	0.00262	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—P2RY11—narcolepsy	0.000253	0.00262	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—HCRT—narcolepsy	0.000252	0.00262	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—HRH3—narcolepsy	0.000252	0.00261	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—HCRT—narcolepsy	0.000252	0.00261	CbGpPWpGaD
Regorafenib—NTRK1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000245	0.00254	CbGpPWpGaD
Regorafenib—RAF1—TNF alpha Signaling Pathway—TNF—narcolepsy	0.000244	0.00253	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000243	0.00252	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—HCRTR2—narcolepsy	0.000242	0.00251	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—HCRTR1—narcolepsy	0.000242	0.00251	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—HCRTR2—narcolepsy	0.000238	0.00247	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—HCRTR1—narcolepsy	0.000238	0.00247	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—PENK—narcolepsy	0.000238	0.00247	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—P2RY11—narcolepsy	0.000234	0.00243	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—P2RY11—narcolepsy	0.00023	0.00239	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—HCRTR2—narcolepsy	0.000226	0.00234	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—HCRTR1—narcolepsy	0.000226	0.00234	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—HCRTR1—narcolepsy	0.000225	0.00234	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—HCRTR2—narcolepsy	0.000225	0.00234	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—PENK—narcolepsy	0.000225	0.00233	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—PENK—narcolepsy	0.000224	0.00233	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—P2RY11—narcolepsy	0.000218	0.00226	CbGpPWpGaD
Regorafenib—BRAF—MAPK Signaling Pathway—TNF—narcolepsy	0.000218	0.00226	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—P2RY11—narcolepsy	0.000218	0.00226	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—HCRT—narcolepsy	0.000217	0.00225	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—HLA-DQA1—narcolepsy	0.000215	0.00223	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—HCRT—narcolepsy	0.000215	0.00223	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—CHKB—narcolepsy	0.000214	0.00222	CbGpPWpGaD
Regorafenib—RAF1—Cytokine Signaling in Immune system—HLA-DRB1—narcolepsy	0.000212	0.0022	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—HLA-DQA1—narcolepsy	0.000211	0.00219	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—NPS—narcolepsy	0.000209	0.00216	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—TAC1—narcolepsy	0.000209	0.00216	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000203	0.00211	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—HCRTR2—narcolepsy	0.000203	0.00211	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—HCRTR1—narcolepsy	0.000203	0.00211	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—TRH—narcolepsy	0.000202	0.0021	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000201	0.00209	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—HLA-DQA1—narcolepsy	0.000201	0.00208	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—HLA-DQA1—narcolepsy	0.0002	0.00207	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—HCRT—narcolepsy	0.000199	0.00206	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000198	0.00205	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—P2RY11—narcolepsy	0.000196	0.00203	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—HCRT—narcolepsy	0.000196	0.00203	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—PENK—narcolepsy	0.000193	0.002	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—PENK—narcolepsy	0.000192	0.00199	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—TRH—narcolepsy	0.000191	0.00198	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—TRH—narcolepsy	0.000191	0.00198	CbGpPWpGaD
Regorafenib—FGFR1—MAPK Signaling Pathway—TNF—narcolepsy	0.000188	0.00195	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000188	0.00195	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000187	0.00194	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—HCRT—narcolepsy	0.000186	0.00192	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—HCRT—narcolepsy	0.000185	0.00192	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000181	0.00188	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—HCRTR2—narcolepsy	0.000181	0.00188	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—HCRTR1—narcolepsy	0.000181	0.00188	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—HLA-DQA1—narcolepsy	0.00018	0.00187	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—PENK—narcolepsy	0.000177	0.00184	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—HRH3—narcolepsy	0.000177	0.00184	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—P2RY11—narcolepsy	0.000175	0.00181	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—PENK—narcolepsy	0.000174	0.00181	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—CPT1B—narcolepsy	0.000172	0.00178	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—CPT1B—narcolepsy	0.000172	0.00178	CbGpPWpGaD
Regorafenib—FGFR1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.00017	0.00176	CbGpPWpGaD
Regorafenib—PDGFRA—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.00017	0.00176	CbGpPWpGaD
Regorafenib—PDGFRB—MAPK Signaling Pathway—TNF—narcolepsy	0.000169	0.00176	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000169	0.00175	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—HTR2A—narcolepsy	0.000168	0.00175	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—HRH3—narcolepsy	0.000168	0.00174	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—HRH3—narcolepsy	0.000167	0.00173	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—HCRT—narcolepsy	0.000167	0.00173	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—PENK—narcolepsy	0.000165	0.00172	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000165	0.00171	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—PENK—narcolepsy	0.000165	0.00171	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—TRH—narcolepsy	0.000164	0.0017	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—TRH—narcolepsy	0.000163	0.00169	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—HLA-DQA1—narcolepsy	0.000161	0.00167	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—CHKB—narcolepsy	0.000157	0.00163	CbGpPWpGaD
Regorafenib—EPHA2—Developmental Biology—TNF—narcolepsy	0.000153	0.00159	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000153	0.00159	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—TRH—narcolepsy	0.000151	0.00156	CbGpPWpGaD
Regorafenib—RAF1—MAPK Signaling Pathway—TNF—narcolepsy	0.000151	0.00156	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—HLA-DRB1—narcolepsy	0.00015	0.00156	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—HLA-DQB1—narcolepsy	0.00015	0.00156	CbGpPWpGaD
Regorafenib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000149	0.00154	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—HCRT—narcolepsy	0.000149	0.00154	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—PENK—narcolepsy	0.000149	0.00154	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—TRH—narcolepsy	0.000148	0.00154	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—TAC1—narcolepsy	0.000147	0.00152	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—NPS—narcolepsy	0.000147	0.00152	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—CPT1B—narcolepsy	0.000146	0.00151	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—HRH3—narcolepsy	0.000144	0.00149	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—HRH3—narcolepsy	0.000143	0.00148	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000143	0.00148	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000142	0.00148	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—HLA-DQA1—narcolepsy	0.000142	0.00147	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—TRH—narcolepsy	0.000141	0.00146	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—TRH—narcolepsy	0.00014	0.00145	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—NPS—narcolepsy	0.000139	0.00144	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—TAC1—narcolepsy	0.000139	0.00144	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—NPS—narcolepsy	0.000139	0.00144	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—TAC1—narcolepsy	0.000139	0.00144	CbGpPWpGaD
Regorafenib—RAF1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000136	0.00141	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—CHKB—narcolepsy	0.000133	0.00138	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—HLA-DQB1—narcolepsy	0.000133	0.00138	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—PENK—narcolepsy	0.000132	0.00137	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—HRH3—narcolepsy	0.000132	0.00137	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—HLA-DQA1—narcolepsy	0.000131	0.00135	CbGpPWpGaD
Regorafenib—ABCB1—Allograft Rejection—TNF—narcolepsy	0.00013	0.00135	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—HRH3—narcolepsy	0.00013	0.00135	CbGpPWpGaD
Regorafenib—KIT—Immune System—HLA-DQA1—narcolepsy	0.000128	0.00133	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000128	0.00133	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—TRH—narcolepsy	0.000126	0.00131	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—HTR2A—narcolepsy	0.000126	0.0013	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—HRH3—narcolepsy	0.000123	0.00128	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—HRH3—narcolepsy	0.000123	0.00128	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—HLA-DQB1—narcolepsy	0.000122	0.00127	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—HLA-DQA1—narcolepsy	0.000122	0.00126	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—HLA-DQA1—narcolepsy	0.000121	0.00126	CbGpPWpGaD
Regorafenib—KIT—Immune System—HLA-DQB1—narcolepsy	0.00012	0.00124	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—TAC1—narcolepsy	0.000119	0.00124	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—NPS—narcolepsy	0.000119	0.00124	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CHKB—narcolepsy	0.000119	0.00123	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—NPS—narcolepsy	0.000118	0.00123	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—TAC1—narcolepsy	0.000118	0.00123	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CHKB—narcolepsy	0.000116	0.0012	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000114	0.00118	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—HLA-DQB1—narcolepsy	0.000114	0.00118	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—HLA-DQB1—narcolepsy	0.000113	0.00118	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TRH—narcolepsy	0.000113	0.00117	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—HRH3—narcolepsy	0.000111	0.00115	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—NPS—narcolepsy	0.00011	0.00114	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—TAC1—narcolepsy	0.00011	0.00114	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—HLA-DQA1—narcolepsy	0.000109	0.00113	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CHKB—narcolepsy	0.000108	0.00112	CbGpPWpGaD
Regorafenib—KDR—Developmental Biology—TNF—narcolepsy	0.000108	0.00112	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—TAC1—narcolepsy	0.000108	0.00112	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—NPS—narcolepsy	0.000108	0.00112	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—CPT1B—narcolepsy	0.000107	0.00111	CbGpPWpGaD
Regorafenib—ABL1—Immune System—HLA-DQA1—narcolepsy	0.000107	0.0011	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—HLA-DQB1—narcolepsy	0.000102	0.00106	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—NPS—narcolepsy	0.000102	0.00106	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—TAC1—narcolepsy	0.000102	0.00106	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—NPS—narcolepsy	0.000102	0.00106	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—TAC1—narcolepsy	0.000102	0.00106	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—HLA-DRB1—narcolepsy	0.000101	0.00105	CbGpPWpGaD
Regorafenib—ABL1—Immune System—HLA-DQB1—narcolepsy	9.96e-05	0.00103	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—HRH3—narcolepsy	9.88e-05	0.00102	CbGpPWpGaD
Regorafenib—RAF1—Immune System—HLA-DQA1—narcolepsy	9.74e-05	0.00101	CbGpPWpGaD
Regorafenib—MAPK11—Developmental Biology—TNF—narcolepsy	9.29e-05	0.000963	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—HLA-DRB1—narcolepsy	9.28e-05	0.000963	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—TAC1—narcolepsy	9.18e-05	0.000952	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—NPS—narcolepsy	9.18e-05	0.000952	CbGpPWpGaD
Regorafenib—KIT—Immune System—HLA-DRB1—narcolepsy	9.12e-05	0.000945	CbGpPWpGaD
Regorafenib—RAF1—Immune System—HLA-DQB1—narcolepsy	9.11e-05	0.000945	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—CPT1B—narcolepsy	9.05e-05	0.000938	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—HTR2A—narcolepsy	8.84e-05	0.000917	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—HLA-DRB1—narcolepsy	8.65e-05	0.000897	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—HLA-DRB1—narcolepsy	8.63e-05	0.000895	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—HTR2A—narcolepsy	8.36e-05	0.000866	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—HTR2A—narcolepsy	8.34e-05	0.000864	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—NPS—narcolepsy	8.19e-05	0.000849	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TAC1—narcolepsy	8.19e-05	0.000849	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CPT1B—narcolepsy	8.08e-05	0.000837	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—TNF—narcolepsy	7.95e-05	0.000824	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CPT1B—narcolepsy	7.88e-05	0.000817	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—HLA-DRB1—narcolepsy	7.77e-05	0.000806	CbGpPWpGaD
Regorafenib—ABL1—Immune System—HLA-DRB1—narcolepsy	7.58e-05	0.000786	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CPT1B—narcolepsy	7.36e-05	0.000764	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—HTR2A—narcolepsy	7.19e-05	0.000745	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CHKB—narcolepsy	7.14e-05	0.000741	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—HTR2A—narcolepsy	7.12e-05	0.000738	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—TNF—narcolepsy	6.96e-05	0.000722	CbGpPWpGaD
Regorafenib—RAF1—Immune System—HLA-DRB1—narcolepsy	6.93e-05	0.000719	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—HTR2A—narcolepsy	6.6e-05	0.000684	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—HTR2A—narcolepsy	6.48e-05	0.000672	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	6.42e-05	0.000666	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—TNF—narcolepsy	6.37e-05	0.00066	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—HTR2A—narcolepsy	6.15e-05	0.000638	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—HTR2A—narcolepsy	6.13e-05	0.000636	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—HTR2A—narcolepsy	5.53e-05	0.000573	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—HTR2A—narcolepsy	4.92e-05	0.000511	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CPT1B—narcolepsy	4.86e-05	0.000504	CbGpPWpGaD
